During the past decade, HAGA Ziekenhuis conducted 138 clinical trials. In the 10-year time frame, 138 clinical trials started and 41 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 30 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HAGA Ziekenhuis" #1 sponsor was "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 11 trials, followed by "The Netherlands Cancer Institute" with 11 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 11 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 10 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 10 trials sponsored. Other sponsors include 146 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HAGA Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 12 trials as a collaborator, "Dutch Cancer Society" with 9 trials as a collaborator, "Borstkanker Onderzoek Groep" with 7 trials as a collaborator, "Erasmus Medical Center" with 6 trials as a collaborator and "Leiden University Medical Center" with 6 trials as a collaborator. Other collaborators include 243 different institutions and companies that were collaborators in the rest 193 trials.

According to Clinical.Site data, the most researched conditions in "HAGA Ziekenhuis" are "Cystic Fibrosis" (13 trials), "Breast Cancer" (11 trials), "Atrial Fibrillation" (7 trials), "Coronary Artery Disease" (7 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "HAGA Ziekenhuis" in a lesser frequency.

Most popular intervention types in "HAGA Ziekenhuis" are "Drug" (136 trials), "Device" (27 trials), "Other" (23 trials), "Procedure" (21 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "IVA" (10 trials), "Docetaxel" (6 trials), "Daratumumab" (5 trials) and "TEZ/IVA" (5 trials). Other intervention names were less common.

The vast majority of trials in "HAGA Ziekenhuis" are 178 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "HAGA Ziekenhuis". 3 are not yet recruiting, 35 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in HAGA Ziekenhuis, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in HAGA Ziekenhuis, 5 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 39 trials that are defined as “Not Applicable".

HAGA Ziekenhuis has several departments that took part in Clinical trials: "HAGA, location Juliana Children's Hospital" - 4 trials, "Leyenburg Ziekenhuis; Internal Medecine" - 2 trials